The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Internal Neuromodulation Market Research Report 2025
Synopsis
Neuromodulation is used to regulate functions of nervous system, such as therapeutic alteration, inhibition, stimulation, modification, and others. There are two types of neuromodulation external neuromodulation and internal neuromodulation. Internal neuromodulation block or repair neuron signals of pain from reaching the brain using electrical impulses. These devices reduce highest levels of pain for various chronic or refractory diseases. Its clinical significance in pain reduction and therapeutics has lead a wide acceptance in the North American region.
The global Internal Neuromodulation market was valued at US$ 2102 million in 2023 and is anticipated to reach US$ 3542.4 million by 2030, witnessing a CAGR of 7.6% during the forecast period 2024-2030.
The driving factors of the internal neuromodulation market are rising prevalence of neurological disorders, increase in the aging population, strong product pipeline, expanded target applications and new indications, and investments and funds. Moreover, technological advancements present opportunities for growth of the market.
This report aims to provide a comprehensive presentation of the global market for Internal Neuromodulation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Internal Neuromodulation.
Report Scope
The Internal Neuromodulation market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Internal Neuromodulation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Internal Neuromodulation companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic PLC
Abbott
Boston Scientific Corp.
Cerbomed GMBH
Cyberonics
Biocontrol Medical
Depuy Synthes Companies
Enteromedics
Synapse Biomedical
Uroplasty
Greatbatch
Abbott Laboratories
Nevro Corporation
NeuroSigma
MicroTransponder
Neuronetics
LivaNova PLC
Bioventus Inc
NeuroPace Inc
Segment by Type
Spinal Cord Stimulator
Deep Brain Stimulator
Sacral Nerve Stimulator
Vagus Nerve Stimulator
Gastric Neuro Stimulator
Segment by Application
Parkinsons Disease
Chronic Pain
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Internal Neuromodulation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Neuromodulation is used to regulate functions of nervous system, such as therapeutic alteration, inhibition, stimulation, modification, and others. There are two types of neuromodulation external neuromodulation and internal neuromodulation. Internal neuromodulation block or repair neuron signals of pain from reaching the brain using electrical impulses. These devices reduce highest levels of pain for various chronic or refractory diseases. Its clinical significance in pain reduction and therapeutics has lead a wide acceptance in the North American region.
The global Internal Neuromodulation market was valued at US$ 2102 million in 2023 and is anticipated to reach US$ 3542.4 million by 2030, witnessing a CAGR of 7.6% during the forecast period 2024-2030.
The driving factors of the internal neuromodulation market are rising prevalence of neurological disorders, increase in the aging population, strong product pipeline, expanded target applications and new indications, and investments and funds. Moreover, technological advancements present opportunities for growth of the market.
This report aims to provide a comprehensive presentation of the global market for Internal Neuromodulation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Internal Neuromodulation.
Report Scope
The Internal Neuromodulation market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Internal Neuromodulation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Internal Neuromodulation companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic PLC
Abbott
Boston Scientific Corp.
Cerbomed GMBH
Cyberonics
Biocontrol Medical
Depuy Synthes Companies
Enteromedics
Synapse Biomedical
Uroplasty
Greatbatch
Abbott Laboratories
Nevro Corporation
NeuroSigma
MicroTransponder
Neuronetics
LivaNova PLC
Bioventus Inc
NeuroPace Inc
Segment by Type
Spinal Cord Stimulator
Deep Brain Stimulator
Sacral Nerve Stimulator
Vagus Nerve Stimulator
Gastric Neuro Stimulator
Segment by Application
Parkinsons Disease
Chronic Pain
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Internal Neuromodulation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Internal Neuromodulation Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Spinal Cord Stimulator
1.2.3 Deep Brain Stimulator
1.2.4 Sacral Nerve Stimulator
1.2.5 Vagus Nerve Stimulator
1.2.6 Gastric Neuro Stimulator
1.3 Market by Application
1.3.1 Global Internal Neuromodulation Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Parkinsons Disease
1.3.3 Chronic Pain
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Internal Neuromodulation Market Perspective (2019-2030)
2.2 Internal Neuromodulation Growth Trends by Region
2.2.1 Global Internal Neuromodulation Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Internal Neuromodulation Historic Market Size by Region (2019-2024)
2.2.3 Internal Neuromodulation Forecasted Market Size by Region (2025-2030)
2.3 Internal Neuromodulation Market Dynamics
2.3.1 Internal Neuromodulation Industry Trends
2.3.2 Internal Neuromodulation Market Drivers
2.3.3 Internal Neuromodulation Market Challenges
2.3.4 Internal Neuromodulation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Internal Neuromodulation Players by Revenue
3.1.1 Global Top Internal Neuromodulation Players by Revenue (2019-2024)
3.1.2 Global Internal Neuromodulation Revenue Market Share by Players (2019-2024)
3.2 Global Internal Neuromodulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Internal Neuromodulation Revenue
3.4 Global Internal Neuromodulation Market Concentration Ratio
3.4.1 Global Internal Neuromodulation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Internal Neuromodulation Revenue in 2023
3.5 Internal Neuromodulation Key Players Head office and Area Served
3.6 Key Players Internal Neuromodulation Product Solution and Service
3.7 Date of Enter into Internal Neuromodulation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Internal Neuromodulation Breakdown Data by Type
4.1 Global Internal Neuromodulation Historic Market Size by Type (2019-2024)
4.2 Global Internal Neuromodulation Forecasted Market Size by Type (2025-2030)
5 Internal Neuromodulation Breakdown Data by Application
5.1 Global Internal Neuromodulation Historic Market Size by Application (2019-2024)
5.2 Global Internal Neuromodulation Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Internal Neuromodulation Market Size (2019-2030)
6.2 North America Internal Neuromodulation Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Internal Neuromodulation Market Size by Country (2019-2024)
6.4 North America Internal Neuromodulation Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Internal Neuromodulation Market Size (2019-2030)
7.2 Europe Internal Neuromodulation Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Internal Neuromodulation Market Size by Country (2019-2024)
7.4 Europe Internal Neuromodulation Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Internal Neuromodulation Market Size (2019-2030)
8.2 Asia-Pacific Internal Neuromodulation Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Internal Neuromodulation Market Size by Region (2019-2024)
8.4 Asia-Pacific Internal Neuromodulation Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Internal Neuromodulation Market Size (2019-2030)
9.2 Latin America Internal Neuromodulation Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Internal Neuromodulation Market Size by Country (2019-2024)
9.4 Latin America Internal Neuromodulation Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Internal Neuromodulation Market Size (2019-2030)
10.2 Middle East & Africa Internal Neuromodulation Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Internal Neuromodulation Market Size by Country (2019-2024)
10.4 Middle East & Africa Internal Neuromodulation Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic PLC
11.1.1 Medtronic PLC Company Detail
11.1.2 Medtronic PLC Business Overview
11.1.3 Medtronic PLC Internal Neuromodulation Introduction
11.1.4 Medtronic PLC Revenue in Internal Neuromodulation Business (2019-2024)
11.1.5 Medtronic PLC Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Internal Neuromodulation Introduction
11.2.4 Abbott Revenue in Internal Neuromodulation Business (2019-2024)
11.2.5 Abbott Recent Development
11.3 Boston Scientific Corp.
11.3.1 Boston Scientific Corp. Company Detail
11.3.2 Boston Scientific Corp. Business Overview
11.3.3 Boston Scientific Corp. Internal Neuromodulation Introduction
11.3.4 Boston Scientific Corp. Revenue in Internal Neuromodulation Business (2019-2024)
11.3.5 Boston Scientific Corp. Recent Development
11.4 Cerbomed GMBH
11.4.1 Cerbomed GMBH Company Detail
11.4.2 Cerbomed GMBH Business Overview
11.4.3 Cerbomed GMBH Internal Neuromodulation Introduction
11.4.4 Cerbomed GMBH Revenue in Internal Neuromodulation Business (2019-2024)
11.4.5 Cerbomed GMBH Recent Development
11.5 Cyberonics
11.5.1 Cyberonics Company Detail
11.5.2 Cyberonics Business Overview
11.5.3 Cyberonics Internal Neuromodulation Introduction
11.5.4 Cyberonics Revenue in Internal Neuromodulation Business (2019-2024)
11.5.5 Cyberonics Recent Development
11.6 Biocontrol Medical
11.6.1 Biocontrol Medical Company Detail
11.6.2 Biocontrol Medical Business Overview
11.6.3 Biocontrol Medical Internal Neuromodulation Introduction
11.6.4 Biocontrol Medical Revenue in Internal Neuromodulation Business (2019-2024)
11.6.5 Biocontrol Medical Recent Development
11.7 Depuy Synthes Companies
11.7.1 Depuy Synthes Companies Company Detail
11.7.2 Depuy Synthes Companies Business Overview
11.7.3 Depuy Synthes Companies Internal Neuromodulation Introduction
11.7.4 Depuy Synthes Companies Revenue in Internal Neuromodulation Business (2019-2024)
11.7.5 Depuy Synthes Companies Recent Development
11.8 Enteromedics
11.8.1 Enteromedics Company Detail
11.8.2 Enteromedics Business Overview
11.8.3 Enteromedics Internal Neuromodulation Introduction
11.8.4 Enteromedics Revenue in Internal Neuromodulation Business (2019-2024)
11.8.5 Enteromedics Recent Development
11.9 Synapse Biomedical
11.9.1 Synapse Biomedical Company Detail
11.9.2 Synapse Biomedical Business Overview
11.9.3 Synapse Biomedical Internal Neuromodulation Introduction
11.9.4 Synapse Biomedical Revenue in Internal Neuromodulation Business (2019-2024)
11.9.5 Synapse Biomedical Recent Development
11.10 Uroplasty
11.10.1 Uroplasty Company Detail
11.10.2 Uroplasty Business Overview
11.10.3 Uroplasty Internal Neuromodulation Introduction
11.10.4 Uroplasty Revenue in Internal Neuromodulation Business (2019-2024)
11.10.5 Uroplasty Recent Development
11.11 Greatbatch
11.11.1 Greatbatch Company Detail
11.11.2 Greatbatch Business Overview
11.11.3 Greatbatch Internal Neuromodulation Introduction
11.11.4 Greatbatch Revenue in Internal Neuromodulation Business (2019-2024)
11.11.5 Greatbatch Recent Development
11.12 Abbott Laboratories
11.12.1 Abbott Laboratories Company Detail
11.12.2 Abbott Laboratories Business Overview
11.12.3 Abbott Laboratories Internal Neuromodulation Introduction
11.12.4 Abbott Laboratories Revenue in Internal Neuromodulation Business (2019-2024)
11.12.5 Abbott Laboratories Recent Development
11.13 Nevro Corporation
11.13.1 Nevro Corporation Company Detail
11.13.2 Nevro Corporation Business Overview
11.13.3 Nevro Corporation Internal Neuromodulation Introduction
11.13.4 Nevro Corporation Revenue in Internal Neuromodulation Business (2019-2024)
11.13.5 Nevro Corporation Recent Development
11.14 NeuroSigma
11.14.1 NeuroSigma Company Detail
11.14.2 NeuroSigma Business Overview
11.14.3 NeuroSigma Internal Neuromodulation Introduction
11.14.4 NeuroSigma Revenue in Internal Neuromodulation Business (2019-2024)
11.14.5 NeuroSigma Recent Development
11.15 MicroTransponder
11.15.1 MicroTransponder Company Detail
11.15.2 MicroTransponder Business Overview
11.15.3 MicroTransponder Internal Neuromodulation Introduction
11.15.4 MicroTransponder Revenue in Internal Neuromodulation Business (2019-2024)
11.15.5 MicroTransponder Recent Development
11.16 Neuronetics
11.16.1 Neuronetics Company Detail
11.16.2 Neuronetics Business Overview
11.16.3 Neuronetics Internal Neuromodulation Introduction
11.16.4 Neuronetics Revenue in Internal Neuromodulation Business (2019-2024)
11.16.5 Neuronetics Recent Development
11.17 LivaNova PLC
11.17.1 LivaNova PLC Company Detail
11.17.2 LivaNova PLC Business Overview
11.17.3 LivaNova PLC Internal Neuromodulation Introduction
11.17.4 LivaNova PLC Revenue in Internal Neuromodulation Business (2019-2024)
11.17.5 LivaNova PLC Recent Development
11.18 Bioventus Inc
11.18.1 Bioventus Inc Company Detail
11.18.2 Bioventus Inc Business Overview
11.18.3 Bioventus Inc Internal Neuromodulation Introduction
11.18.4 Bioventus Inc Revenue in Internal Neuromodulation Business (2019-2024)
11.18.5 Bioventus Inc Recent Development
11.19 NeuroPace Inc
11.19.1 NeuroPace Inc Company Detail
11.19.2 NeuroPace Inc Business Overview
11.19.3 NeuroPace Inc Internal Neuromodulation Introduction
11.19.4 NeuroPace Inc Revenue in Internal Neuromodulation Business (2019-2024)
11.19.5 NeuroPace Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Internal Neuromodulation Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Spinal Cord Stimulator
Table 3. Key Players of Deep Brain Stimulator
Table 4. Key Players of Sacral Nerve Stimulator
Table 5. Key Players of Vagus Nerve Stimulator
Table 6. Key Players of Gastric Neuro Stimulator
Table 7. Global Internal Neuromodulation Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Internal Neuromodulation Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Internal Neuromodulation Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Internal Neuromodulation Market Share by Region (2019-2024)
Table 11. Global Internal Neuromodulation Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Internal Neuromodulation Market Share by Region (2025-2030)
Table 13. Internal Neuromodulation Market Trends
Table 14. Internal Neuromodulation Market Drivers
Table 15. Internal Neuromodulation Market Challenges
Table 16. Internal Neuromodulation Market Restraints
Table 17. Global Internal Neuromodulation Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Internal Neuromodulation Market Share by Players (2019-2024)
Table 19. Global Top Internal Neuromodulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Internal Neuromodulation as of 2023)
Table 20. Ranking of Global Top Internal Neuromodulation Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Internal Neuromodulation Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Internal Neuromodulation Product Solution and Service
Table 24. Date of Enter into Internal Neuromodulation Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Internal Neuromodulation Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Internal Neuromodulation Revenue Market Share by Type (2019-2024)
Table 28. Global Internal Neuromodulation Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Internal Neuromodulation Revenue Market Share by Type (2025-2030)
Table 30. Global Internal Neuromodulation Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Internal Neuromodulation Revenue Market Share by Application (2019-2024)
Table 32. Global Internal Neuromodulation Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Internal Neuromodulation Revenue Market Share by Application (2025-2030)
Table 34. North America Internal Neuromodulation Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Internal Neuromodulation Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Internal Neuromodulation Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Internal Neuromodulation Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Internal Neuromodulation Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Internal Neuromodulation Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Internal Neuromodulation Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Internal Neuromodulation Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Internal Neuromodulation Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Internal Neuromodulation Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Internal Neuromodulation Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Internal Neuromodulation Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Internal Neuromodulation Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Internal Neuromodulation Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Internal Neuromodulation Market Size by Country (2025-2030) & (US$ Million)
Table 49. Medtronic PLC Company Detail
Table 50. Medtronic PLC Business Overview
Table 51. Medtronic PLC Internal Neuromodulation Product
Table 52. Medtronic PLC Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)
Table 53. Medtronic PLC Recent Development
Table 54. Abbott Company Detail
Table 55. Abbott Business Overview
Table 56. Abbott Internal Neuromodulation Product
Table 57. Abbott Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)
Table 58. Abbott Recent Development
Table 59. Boston Scientific Corp. Company Detail
Table 60. Boston Scientific Corp. Business Overview
Table 61. Boston Scientific Corp. Internal Neuromodulation Product
Table 62. Boston Scientific Corp. Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)
Table 63. Boston Scientific Corp. Recent Development
Table 64. Cerbomed GMBH Company Detail
Table 65. Cerbomed GMBH Business Overview
Table 66. Cerbomed GMBH Internal Neuromodulation Product
Table 67. Cerbomed GMBH Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)
Table 68. Cerbomed GMBH Recent Development
Table 69. Cyberonics Company Detail
Table 70. Cyberonics Business Overview
Table 71. Cyberonics Internal Neuromodulation Product
Table 72. Cyberonics Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)
Table 73. Cyberonics Recent Development
Table 74. Biocontrol Medical Company Detail
Table 75. Biocontrol Medical Business Overview
Table 76. Biocontrol Medical Internal Neuromodulation Product
Table 77. Biocontrol Medical Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)
Table 78. Biocontrol Medical Recent Development
Table 79. Depuy Synthes Companies Company Detail
Table 80. Depuy Synthes Companies Business Overview
Table 81. Depuy Synthes Companies Internal Neuromodulation Product
Table 82. Depuy Synthes Companies Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)
Table 83. Depuy Synthes Companies Recent Development
Table 84. Enteromedics Company Detail
Table 85. Enteromedics Business Overview
Table 86. Enteromedics Internal Neuromodulation Product
Table 87. Enteromedics Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)
Table 88. Enteromedics Recent Development
Table 89. Synapse Biomedical Company Detail
Table 90. Synapse Biomedical Business Overview
Table 91. Synapse Biomedical Internal Neuromodulation Product
Table 92. Synapse Biomedical Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)
Table 93. Synapse Biomedical Recent Development
Table 94. Uroplasty Company Detail
Table 95. Uroplasty Business Overview
Table 96. Uroplasty Internal Neuromodulation Product
Table 97. Uroplasty Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)
Table 98. Uroplasty Recent Development
Table 99. Greatbatch Company Detail
Table 100. Greatbatch Business Overview
Table 101. Greatbatch Internal Neuromodulation Product
Table 102. Greatbatch Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)
Table 103. Greatbatch Recent Development
Table 104. Abbott Laboratories Company Detail
Table 105. Abbott Laboratories Business Overview
Table 106. Abbott Laboratories Internal Neuromodulation Product
Table 107. Abbott Laboratories Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)
Table 108. Abbott Laboratories Recent Development
Table 109. Nevro Corporation Company Detail
Table 110. Nevro Corporation Business Overview
Table 111. Nevro Corporation Internal Neuromodulation Product
Table 112. Nevro Corporation Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)
Table 113. Nevro Corporation Recent Development
Table 114. NeuroSigma Company Detail
Table 115. NeuroSigma Business Overview
Table 116. NeuroSigma Internal Neuromodulation Product
Table 117. NeuroSigma Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)
Table 118. NeuroSigma Recent Development
Table 119. MicroTransponder Company Detail
Table 120. MicroTransponder Business Overview
Table 121. MicroTransponder Internal Neuromodulation Product
Table 122. MicroTransponder Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)
Table 123. MicroTransponder Recent Development
Table 124. Neuronetics Company Detail
Table 125. Neuronetics Business Overview
Table 126. Neuronetics Internal Neuromodulation Product
Table 127. Neuronetics Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)
Table 128. Neuronetics Recent Development
Table 129. LivaNova PLC Company Detail
Table 130. LivaNova PLC Business Overview
Table 131. LivaNova PLC Internal Neuromodulation Product
Table 132. LivaNova PLC Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)
Table 133. LivaNova PLC Recent Development
Table 134. Bioventus Inc Company Detail
Table 135. Bioventus Inc Business Overview
Table 136. Bioventus Inc Internal Neuromodulation Product
Table 137. Bioventus Inc Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)
Table 138. Bioventus Inc Recent Development
Table 139. NeuroPace Inc Company Detail
Table 140. NeuroPace Inc Business Overview
Table 141. NeuroPace Inc Internal Neuromodulation Product
Table 142. NeuroPace Inc Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)
Table 143. NeuroPace Inc Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Internal Neuromodulation Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Internal Neuromodulation Market Share by Type: 2023 VS 2030
Figure 3. Spinal Cord Stimulator Features
Figure 4. Deep Brain Stimulator Features
Figure 5. Sacral Nerve Stimulator Features
Figure 6. Vagus Nerve Stimulator Features
Figure 7. Gastric Neuro Stimulator Features
Figure 8. Global Internal Neuromodulation Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Internal Neuromodulation Market Share by Application: 2023 VS 2030
Figure 10. Parkinsons Disease Case Studies
Figure 11. Chronic Pain Case Studies
Figure 12. Others Case Studies
Figure 13. Internal Neuromodulation Report Years Considered
Figure 14. Global Internal Neuromodulation Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Internal Neuromodulation Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Internal Neuromodulation Market Share by Region: 2023 VS 2030
Figure 17. Global Internal Neuromodulation Market Share by Players in 2023
Figure 18. Global Top Internal Neuromodulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Internal Neuromodulation as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Internal Neuromodulation Revenue in 2023
Figure 20. North America Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Internal Neuromodulation Market Share by Country (2019-2030)
Figure 22. United States Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Internal Neuromodulation Market Share by Country (2019-2030)
Figure 26. Germany Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Internal Neuromodulation Market Share by Region (2019-2030)
Figure 34. China Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Internal Neuromodulation Market Share by Country (2019-2030)
Figure 42. Mexico Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Internal Neuromodulation Market Share by Country (2019-2030)
Figure 46. Turkey Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Medtronic PLC Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)
Figure 49. Abbott Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)
Figure 50. Boston Scientific Corp. Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)
Figure 51. Cerbomed GMBH Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)
Figure 52. Cyberonics Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)
Figure 53. Biocontrol Medical Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)
Figure 54. Depuy Synthes Companies Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)
Figure 55. Enteromedics Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)
Figure 56. Synapse Biomedical Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)
Figure 57. Uroplasty Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)
Figure 58. Greatbatch Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)
Figure 59. Abbott Laboratories Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)
Figure 60. Nevro Corporation Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)
Figure 61. NeuroSigma Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)
Figure 62. MicroTransponder Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)
Figure 63. Neuronetics Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)
Figure 64. LivaNova PLC Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)
Figure 65. Bioventus Inc Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)
Figure 66. NeuroPace Inc Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
